Ann: 2014/2015 Half Year Financial Report, page-30

I don't think you're out of school at all Furian, all great questions which really highlights how many unknowns we unfortunately have to currently contend with. You're a welcome addition to the board! I have no great knowledge into clinical trials costs or coal for that matter and can only offer what AVX management have said which is that the final trial costs will be circa $30m. It's been a long time coming but a fascinating strategy nonetheless, one which they seem to be progressing towards executing. Hopefully the market for the product is still there when they get there and they can sell plenty of it! I was pleased to see Kirkwood picking up a few more shares on market at $0.016 in early March, along with the recently announced hiring intentions for a new MD/CEO - neither actions I would generally associate with a firm just about to go bust... This is a bottom drawer story for me, hopefully it gets there..